Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Pharmaceutical Preparations × Other neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 3 Plasma cell 1 Other neoplasm 1 Myeloid 1 Dermatologic 1 CNS 1

Conditions

Rare Malignant Neoplasm 1

Interventions

Polymerase Chain Reaction 4 Immunohistochemistry 3 Gene Expression Profiling 3 Blood Specimen Collection 3 Microarray Analysis 2 Mass Spectrometry 2 Interviews as Topic 2 Cytogenetic Analysis 2 Comparative Genomic Hybridization 2 Biopsy 2 tremelimumab 1 Watchful Waiting 1 Ultrasonography, Doppler 1 Tomography, Optical Coherence 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Ribavirin 1 Pharmaceutical Preparations 1 Papanicolaou Test 1 Observation 1 Methylation 1 Infliximab 1 In Situ Hybridization, Fluorescence 1 Immunoenzyme Techniques 1 Histological Techniques 1 High-Energy Shock Waves 1 Genetic Linkage 1 Flow Cytometry 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06872853 2025-03-12

RAC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡